Two abstracts presented at the American Thoracic Society 2024 International Conference analyzed the phase 3 LIBERTY COPD BOREAS trial, finding that dupilumab improves pre- and post-bronchodilator lung ...
Hypercapnic patients were best separated from normocapnic patients using thresholds for FVC% of 56% predicted and 33% predicted for FEV1%. Hypercapnia in patients with chronic obstructive pulmonary ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Oral nerandomilast doses of 9 mg and 18 mg were ...
Please provide your email address to receive an email when new articles are posted on . AI model lung function estimations agreed with spirometry. With the model, there were high area under the ...
SAN FRANCISCO — The investigational oral agent nerandomilast was superior to placebo at slowing the decline in forced vital capacity (FVC) among patients with progressive pulmonary fibrosis (PF), ...
Patients with chronic obstructive pulmonary disease (COPD) and/or preserved ratio impaired spirometry (PRISm) have an increased risk of all-cause and cause-specific mortality, highlighting the need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results